RU2092483C1 - Производные хромана или тиохромана и способы их получения (варианты) - Google Patents

Производные хромана или тиохромана и способы их получения (варианты) Download PDF

Info

Publication number
RU2092483C1
RU2092483C1 SU905001901A SU5001901A RU2092483C1 RU 2092483 C1 RU2092483 C1 RU 2092483C1 SU 905001901 A SU905001901 A SU 905001901A SU 5001901 A SU5001901 A SU 5001901A RU 2092483 C1 RU2092483 C1 RU 2092483C1
Authority
RU
Russia
Prior art keywords
alkyl
hydrogen
mmol
compound
salt
Prior art date
Application number
SU905001901A
Other languages
English (en)
Russian (ru)
Inventor
Ларссон Ларс-Гюннар
Норен Рольф
Анна Рени Люси
Бертил Росс Сванте
Дунганн Сонн Даниель
Эрик Свенссон Бьерн
Олов Торберг Сет
Original Assignee
Астра Актиеболаг
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Астра Актиеболаг filed Critical Астра Актиеболаг
Application granted granted Critical
Publication of RU2092483C1 publication Critical patent/RU2092483C1/ru

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
    • C07D335/04—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D335/06—Benzothiopyrans; Hydrogenated benzothiopyrans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pyrane Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Threshing Machine Elements (AREA)
  • Liquid Crystal Substances (AREA)
  • Bakery Products And Manufacturing Methods Therefor (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
  • Medicinal Preparation (AREA)
  • Curing Cements, Concrete, And Artificial Stone (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Harvester Elements (AREA)
  • Apparatuses For Bulk Treatment Of Fruits And Vegetables And Apparatuses For Preparing Feeds (AREA)
SU905001901A 1989-12-22 1990-12-19 Производные хромана или тиохромана и способы их получения (варианты) RU2092483C1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE8904361A SE8904361D0 (sv) 1989-12-22 1989-12-22 New chroman and thiochroman derivatives
SE8904361-6 1989-12-22
PCT/SE1990/000863 WO1991009853A1 (en) 1989-12-22 1990-12-19 New chroman and thiochroman derivatives

Publications (1)

Publication Number Publication Date
RU2092483C1 true RU2092483C1 (ru) 1997-10-10

Family

ID=20377869

Family Applications (1)

Application Number Title Priority Date Filing Date
SU905001901A RU2092483C1 (ru) 1989-12-22 1990-12-19 Производные хромана или тиохромана и способы их получения (варианты)

Country Status (42)

Country Link
EP (1) EP0460169B1 (en:Method)
JP (1) JP2879972B2 (en:Method)
KR (1) KR0178991B1 (en:Method)
CN (1) CN1037438C (en:Method)
AT (1) ATE138918T1 (en:Method)
AU (1) AU641204B2 (en:Method)
CA (1) CA2047237C (en:Method)
CY (1) CY1991A (en:Method)
CZ (1) CZ283630B6 (en:Method)
DE (1) DE69027311T2 (en:Method)
DK (1) DK0460169T3 (en:Method)
DZ (1) DZ1469A1 (en:Method)
EG (1) EG19749A (en:Method)
ES (1) ES2087993T3 (en:Method)
FI (1) FI102177B (en:Method)
GR (1) GR3020497T3 (en:Method)
HK (1) HK55897A (en:Method)
HR (1) HRP920851B1 (en:Method)
HU (1) HU211860A9 (en:Method)
ID (1) ID945B (en:Method)
IE (1) IE80753B1 (en:Method)
IL (1) IL96712A (en:Method)
IS (1) IS1665B (en:Method)
LT (1) LT3967B (en:Method)
LV (2) LV10449B (en:Method)
MX (1) MX23889A (en:Method)
NO (1) NO180336C (en:Method)
NZ (1) NZ236407A (en:Method)
PH (1) PH30797A (en:Method)
PL (3) PL164592B1 (en:Method)
PT (1) PT96304B (en:Method)
RU (1) RU2092483C1 (en:Method)
SA (1) SA90110186B1 (en:Method)
SE (1) SE8904361D0 (en:Method)
SG (1) SG48043A1 (en:Method)
SI (1) SI9012429B (en:Method)
SK (1) SK657890A3 (en:Method)
TW (1) TW221056B (en:Method)
UA (1) UA34416C2 (en:Method)
WO (1) WO1991009853A1 (en:Method)
YU (2) YU47936B (en:Method)
ZA (1) ZA909708B (en:Method)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2193559C1 (ru) * 2001-05-16 2002-11-27 Пермская государственная фармацевтическая академия 2,4-ксилидид и м-фенетидид 2-ацетилиминокумарин-3-карбоновой кислоты, обладающие антикоагулянтной активностью
RU2225389C2 (ru) * 1998-07-31 2004-03-10 Акцо Нобель Н.В. Производные аминометилкарбоновой кислоты и фармацевтическая композиция на их основе
RU2460730C2 (ru) * 2007-04-23 2012-09-10 Астразенека Аб Новые производные n-(8-гетероарилтетрагидронафталин-2-ил)-или n-(5-гетероарилхроман-3-ил)-карбоксамида для лечения боли
US10329268B2 (en) 2013-09-13 2019-06-25 Bial-Portela & Ca, S.A. Processes for preparing medicaments for the treatment of cardiovascular diseases and intermediates for use therein

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5420151A (en) * 1989-12-22 1995-05-30 Aktiebolaget Astra Chroman derivatives
EP0471515B1 (en) * 1990-08-15 1997-03-05 Eli Lilly And Company Ring-substituted 2-amino-1,2,3,4-tetra-hydronaphthalenes, 3-aminochromanes and 3-aminothiochromanes
DK0498590T3 (da) * 1991-02-08 1997-05-05 Lilly Co Eli Ringsubstituerede 2-amino-1,2,3,4-tetrahydronaphthalener
HRP920935A2 (en) * 1991-10-08 1995-08-31 Astra Ab New therapeutically active compound
SE9103745D0 (sv) * 1991-12-18 1991-12-18 Wikstroem Haakan Aryl-triflates and related compounds
FR2691149B1 (fr) * 1992-05-18 1994-07-08 Adir Nouveaux composes thiochromaniques, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.
US5434174A (en) * 1992-07-17 1995-07-18 Eli Lilly And Company Isoxazole derivatives for the treatment of irritable bowel syndrome
SE9301732D0 (sv) * 1993-05-18 1993-05-18 Haakan Wilhelm Wikstroem New centrally acting 5-,6-,7-, and 8-substituted sulphone esters of n-monosubstituted 2-aminotetralins
SE9703377D0 (sv) 1997-09-18 1997-09-18 Astra Ab New compounds
SE9703378D0 (sv) * 1997-09-18 1997-09-18 Astra Ab New compounds
US6184226B1 (en) 1998-08-28 2001-02-06 Scios Inc. Quinazoline derivatives as inhibitors of P-38 α
NZ526699A (en) * 2001-01-16 2005-03-24 Astrazeneca Ab 8-amino derivatives and their use in treating migraine
BR0206513A (pt) 2001-01-16 2004-01-06 Astrazeneca Ab Composição, métodos de tratamento de um ser humano ou animal que sofre de depressão, ansiedade generalizada, distúrbios da alimentação, demência, distúrbio do p nico, distúrbios do sono, distúrbios gastrointestinais, distúrbios motores, distúrbios endócrinos, vasoespasmo e disfunção sexual, uso de qualquer um dos compostos, composição farmacêutica, e, processo para preparar compostos
MXPA03006250A (es) 2001-01-16 2003-09-22 Astrazeneca Ab Compuestos heterociclicos terapeuticos.
US7504395B2 (en) 2001-07-20 2009-03-17 Psychogenics, Inc. Treatment for attention-deficit hyperactivity disorder
US7125904B2 (en) 2002-10-11 2006-10-24 Portela & C.A., S.A. Peripherally-selective inhibitors of dopamine-β-hydroxylase and method of their preparation
SE0301796D0 (sv) * 2003-06-19 2003-06-19 Astrazeneca Ab New use II
SE0301795D0 (sv) * 2003-06-19 2003-06-19 Astrazeneca Ab New use I
US20080221193A1 (en) * 2006-12-22 2008-09-11 Wyeth 3-amino chromane derivatives
CN101712672B (zh) * 2008-10-06 2013-02-06 中国中医科学院中药研究所 一种治疗心脑血管系统疾病新化合物及其制备方法、用途
DE102010041948A1 (de) 2010-10-04 2012-04-05 Mahle International Gmbh Filtereinrichtung
CN116655242A (zh) * 2023-05-10 2023-08-29 东北大学 一系列有机-无机杂化金属卤化物玻璃材料及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR862239B (en) * 1985-09-03 1986-12-31 Ciba Geigy Ag 3-amino-dihydro-(1)-benzopyrans and benzothiopyrans
US4801605A (en) * 1986-08-29 1989-01-31 Ciba-Geigy Corporation 3-amino-dihydro-[1]-benzopyrans and benzothiopyrans
SE8605504D0 (sv) * 1986-12-19 1986-12-19 Astra Laekemedel Ab Novel chroman derivatives
US5258287A (en) * 1988-03-22 1993-11-02 Genentech, Inc. DNA encoding and methods of production of insulin-like growth factor binding protein BP53

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
US, патент, 4782083, кл. A 61 K 31/35, 1988. *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2225389C2 (ru) * 1998-07-31 2004-03-10 Акцо Нобель Н.В. Производные аминометилкарбоновой кислоты и фармацевтическая композиция на их основе
RU2193559C1 (ru) * 2001-05-16 2002-11-27 Пермская государственная фармацевтическая академия 2,4-ксилидид и м-фенетидид 2-ацетилиминокумарин-3-карбоновой кислоты, обладающие антикоагулянтной активностью
RU2460730C2 (ru) * 2007-04-23 2012-09-10 Астразенека Аб Новые производные n-(8-гетероарилтетрагидронафталин-2-ил)-или n-(5-гетероарилхроман-3-ил)-карбоксамида для лечения боли
US10329268B2 (en) 2013-09-13 2019-06-25 Bial-Portela & Ca, S.A. Processes for preparing medicaments for the treatment of cardiovascular diseases and intermediates for use therein

Also Published As

Publication number Publication date
YU47936B (sh) 1996-05-20
GR3020497T3 (en) 1996-10-31
HK55897A (en) 1997-05-09
ZA909708B (en) 1991-08-28
NO180336C (no) 1997-04-02
CZ283630B6 (cs) 1998-05-13
LT3967B (en) 1996-05-27
DE69027311D1 (en) 1996-07-11
WO1991009853A1 (en) 1991-07-11
YU242990A (sh) 1993-10-20
DZ1469A1 (fr) 2004-09-13
NO913273L (no) 1991-10-08
CN1052669A (zh) 1991-07-03
HRP920851A2 (en) 1995-10-31
IS1665B (is) 1997-07-04
JPH04503682A (ja) 1992-07-02
SK280261B6 (sk) 1999-10-08
SK657890A3 (en) 1999-10-08
PH30797A (en) 1997-10-17
KR920701193A (ko) 1992-08-11
LV11894A (lv) 1997-12-20
PL164608B1 (pl) 1994-08-31
EG19749A (en) 1996-01-31
HU211860A9 (en) 1995-12-28
SI9012429A (en) 1997-12-31
EP0460169A1 (en) 1991-12-11
NO913273D0 (no) 1991-08-21
LV10449B (en) 1995-10-20
ES2087993T3 (es) 1996-08-01
CN1037438C (zh) 1998-02-18
JP2879972B2 (ja) 1999-04-05
ID945B (id) 1996-09-20
YU47923B (sh) 1996-05-20
PL164592B1 (pl) 1994-08-31
YU72191A (sh) 1995-01-31
KR0178991B1 (ko) 1999-03-20
ATE138918T1 (de) 1996-06-15
LV11894B (en) 1998-05-20
PL293065A1 (en) 1992-08-10
LTIP1730A (en) 1995-08-25
DK0460169T3 (da) 1996-09-23
AU6977091A (en) 1991-07-24
PL164609B1 (en) 1994-08-31
CA2047237C (en) 2003-02-11
IE80753B1 (en) 1999-01-13
PT96304A (pt) 1991-09-30
CY1991A (en) 1997-09-05
MX23889A (es) 1993-10-01
PT96304B (pt) 1998-09-30
SE8904361D0 (sv) 1989-12-22
FI102177B1 (fi) 1998-10-30
PL293066A1 (en) 1992-08-10
AU641204B2 (en) 1993-09-16
IL96712A (en) 1995-08-31
SA90110186B1 (ar) 2001-11-11
EP0460169B1 (en) 1996-06-05
IL96712A0 (en) 1991-09-16
SG48043A1 (en) 1998-04-17
DE69027311T2 (de) 1996-10-24
NZ236407A (en) 1993-08-26
FI913943A0 (fi) 1991-08-21
IS3662A7 (is) 1991-06-23
TW221056B (en:Method) 1994-02-11
LV10449A (lv) 1995-02-20
HRP920851B1 (en) 2000-02-29
CZ657890A3 (cs) 1998-02-18
UA34416C2 (uk) 2001-03-15
FI102177B (fi) 1998-10-30
SI9012429B (sl) 1998-10-31
IE904535A1 (en) 1991-07-03
NO180336B (no) 1996-12-23
CA2047237A1 (en) 1991-06-23

Similar Documents

Publication Publication Date Title
US5500425A (en) Chroman derivatives and a method of treating 5-HT mediated disorders
CZ283630B6 (cs) Chromanový derivát, způsob jeho výroby a farmaceutický prostředek s jeho obsahem
US6956052B2 (en) Substituted pyrazolyl compounds for the treatment of inflammation
JP2007520440A (ja) ムスカリン性受容体アゴニストとしてのインダン誘導体
JP3283892B2 (ja) 環置換２−アミノ−１，２，３，４−テトラヒドロナフタレン類および３−アミノクロマン類
JP2001521529A (ja) 置換へテロ芳香環５−ｈｔ▲下１ｆ▼アゴニスト
CZ256090A3 (cs) Derivát v poloze 8-substituovaného 2-aminotetralinu, způsoby jeho přípravy, farmaceutický prostředek s jeho obsahem a použití
JP2006522012A (ja) ベンゾキサゾシンおよびそのモノアミン再吸収阻害剤としての用途
JPH09506638A (ja) アリールおよびヘテロアリールアルコキシナフタレン誘導体
WO2010090680A1 (en) Substituted oxindole cb2 agonists
NO301327B1 (no) Tienocyklopentanonoksimetere, og farmasöytiske blandinger som inneholder dem
WO2024169788A1 (zh) 稠环化合物及其用途
CN121914087A (zh) 嘧啶类化合物及其制备方法、药物组合物和用途

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20061220

REG Reference to a code of a succession state

Ref country code: RU

Ref legal event code: MM4A

Effective date: 20061220